Sarepta Therapeutics, Inc. (SRPT)

NASDAQ: SRPT · Real-Time Price · USD

Compare

22.17

+0.31 (1.42%)

At close: Dec 9, 2025, 4:00 PM EST

22.16

-0.01 (-0.05%)

After-hours: Dec 9, 2025, 5:59 PM EST

Sarepta Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	2,414	1,902	1,243	933.01	701.89	540.1	Upgrade
Revenue Growth (YoY)	47.15%	52.97%	33.26%	32.93%	29.95%	41.82%	Upgrade
Cost of Revenue	1,970	1,124	1,028	1,017	862.13	785.63	Upgrade
Gross Profit	443.83	778.36	215.61	-84.07	-160.24	-245.53	Upgrade
Selling, General & Admin	527.29	557.87	481.87	451.42	282.66	317.88	Upgrade
Amortization of Goodwill & Intangibles	2.55	2.41	1.56	0.71	0.71	0.66	Upgrade
Operating Expenses	529.84	560.28	483.43	452.14	283.37	318.54	Upgrade
Operating Income	-86.01	218.08	-267.82	-536.2	-443.61	-564.06	Upgrade
Interest Expense	-21.77	-18.39	-22.01	-53.25	-63.53	-59.95	Upgrade
Interest & Investment Income	30.58	30.64	36.26	16.49	0.35	2.97	Upgrade
Other Non Operating Income (Expenses)	-4.29	-2.85	0.62	-6.92	-0.94	0.52	Upgrade
EBT Excluding Unusual Items	-81.5	227.48	-252.96	-579.88	-507.72	-620.52	Upgrade
Merger & Restructuring Charges	-40.51	-	-	-	-	-	Upgrade
Gain (Loss) on Sale of Investments	-3.39	41.13	19.39	8.66	-4.33	4.49	Upgrade
Gain (Loss) on Sale of Assets	-	-	102	-	102	108.07	Upgrade
Asset Writedown	-	-	-	-	-	-0.1	Upgrade
Other Unusual Items	-126.79	-7.84	-388.53	-118.74	-8.9	-45	Upgrade
Pretax Income	-252.19	260.77	-520.1	-689.96	-418.95	-553.07	Upgrade
Income Tax Expense	19.33	25.54	15.88	13.53	-0.17	1.06	Upgrade
Net Income	-271.51	235.24	-535.98	-703.49	-418.78	-554.13	Upgrade
Net Income to Common	-271.51	235.24	-535.98	-703.49	-418.78	-554.13	Upgrade
Shares Outstanding (Basic)	98	95	92	88	81	78	Upgrade
Shares Outstanding (Diluted)	98	108	92	88	81	78	Upgrade
Shares Change (YoY)	-2.62%	16.75%	5.53%	7.75%	4.24%	5.90%	Upgrade
EPS (Basic)	-2.77	2.47	-5.80	-8.03	-5.15	-7.11	Upgrade
EPS (Diluted)	-2.77	2.34	-5.80	-8.03	-5.15	-7.11	Upgrade
Free Cash Flow	-381.1	-342.74	-577.1	-356.17	-481.66	25.26	Upgrade
Free Cash Flow Per Share	-3.89	-3.18	-6.25	-4.07	-5.93	0.32	Upgrade
Gross Margin	18.39%	40.92%	17.34%	-9.01%	-22.83%	-45.46%	Upgrade
Operating Margin	-3.56%	11.47%	-21.54%	-57.47%	-63.20%	-104.44%	Upgrade
Profit Margin	-11.25%	12.37%	-43.11%	-75.40%	-59.66%	-102.60%	Upgrade
Free Cash Flow Margin	-15.79%	-18.02%	-46.41%	-38.17%	-68.62%	4.68%	Upgrade
EBITDA	-36.28	255.81	-223.43	-494.34	-405.59	-537.6	Upgrade
EBITDA Margin	-1.50%	13.45%	-17.97%	-52.98%	-57.79%	-99.54%	Upgrade
D&A For EBITDA	49.72	37.72	44.4	41.86	38.02	26.46	Upgrade
EBIT	-86.01	218.08	-267.82	-536.2	-443.61	-564.06	Upgrade
EBIT Margin	-3.56%	11.47%	-21.54%	-57.47%	-63.20%	-104.44%	Upgrade
Effective Tax Rate	-	9.79%	-	-	-	-	Upgrade
Revenue as Reported	2,414	1,902	1,243	933.01	701.89	540.1	Upgrade
Advertising Expenses	-	32	28.6	14.6	7.7	-	Upgrade

Updated Nov 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q